论文信息 - A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study - 字舞流文

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study

A. Segura‐Carretero | S. Verdura | E. Cuyás | E. López-Bonet | B. Martín-Castillo | J. Menéndez | S. Fernández-Arroyo | J. Joven | I. Álvarez | Álvaro Fernández-Ochoa | J. Cortés | I. Morilla | M. Buxó | N. Batista-López | S. Pernas | S. Domínguez | M. Luque | A. Stradella | S. Martínez | C. Rodríguez-Sánchez | N. Bosch | K. Amillano | J. Dorca | G. Viñas | Samiha Saidani | J. Peréz-García | Margarita García | E. Pérez | Á. Fernández-Ochoa